Nexlizet 180-10 MG tablet UU 30S
Ended Awarded
- Contract number
- SPE2DB25FVVUA
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,621
Award facts
- Contract value 100% obligated
- $1,621.05 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $1,621.05 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of Nexlizet 180-10 mg tablets (30-count units). This is a non-set-aside, competitively awarded contract with an ultimate completion date of August 1, 2025, and performance to be fulfilled from the vendor's Conshohocken, Pennsylvania location. The delivery order represents a child contract executed under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion pharmaceutical supply agreement running through December 2026 that enables the company to furnish a comprehensive range of medications, vaccines, medical supplies, and specialty pharmaceuticals to support military healthcare programs globally.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical federal vendor for medical procurement across the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's extensive federal contract portfolio demonstrates consistent capability in fulfilling competitive pharmaceutical procurement requirements across multiple therapeutic domains, from specialty medications to generic drugs. This particular delivery order for Nexlizet, an antihyperlipidemic combination medication, reflects the company's ongoing role in supplying essential pharmaceuticals to support military and federal healthcare operations.
Quick answers
Who was awarded contract SPE2DB25FVVUA?
SPE2DB25FVVUA was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on July 31, 2025.
How much is contract SPE2DB25FVVUA worth?
The government has obligated $1,621 on SPE2DB25FVVUA.
Is contract SPE2DB25FVVUA an order under another contract?
Yes. SPE2DB25FVVUA is a delivery order under SPE2DB25D3504, an indefinite delivery contract.
Was contract SPE2DB25FVVUA competed?
The extent of competition for SPE2DB25FVVUA was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award